Stefania Perdichizzi

1.6k total citations
26 papers, 1.2k citations indexed

About

Stefania Perdichizzi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stefania Perdichizzi has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stefania Perdichizzi's work include Carcinogens and Genotoxicity Assessment (7 papers), Sarcoma Diagnosis and Treatment (6 papers) and Computational Drug Discovery Methods (3 papers). Stefania Perdichizzi is often cited by papers focused on Carcinogens and Genotoxicity Assessment (7 papers), Sarcoma Diagnosis and Treatment (6 papers) and Computational Drug Discovery Methods (3 papers). Stefania Perdichizzi collaborates with scholars based in Italy, United Kingdom and Canada. Stefania Perdichizzi's co-authors include Stefania Benini, Katia Scotlandi, Maria Cristina Manara, Piero Picci, Massimo Serra, Pier‐Luigi Lollini, Vanessa Cerisano, Rosaria Strammiello, Giordano Nicoletti and Franco Bertoni and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Stefania Perdichizzi

26 papers receiving 1.1k citations

Peers

Countries citing papers authored by Stefania Perdichizzi

Since Specialization

Citations

This map shows the geographic impact of Stefania Perdichizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Perdichizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Perdichizzi more than expected).

Fields of papers citing papers by Stefania Perdichizzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Perdichizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Perdichizzi. The network helps show where Stefania Perdichizzi may publish in the future.

Co-authorship network of co-authors of Stefania Perdichizzi

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Perdichizzi. A scholar is included among the top collaborators of Stefania Perdichizzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Perdichizzi. Stefania Perdichizzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transcriptomics and Cell Transformation Assay: an Integrated Approach to Evaluate the Effects of Low Dose Ionizing Radiation 2021 ·Stefania Perdichizzi, Maria Grazia Mascolo, Francesca Rotondo, Monica Vaccari, Sandro Grilli, Annamaria Colacci, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	Framework for the quality assurance of ’omics technologies considering GLP requirements 2017 ·Regulatory Toxicology and Pharmacology ·Hans-Martin Kauffmann, Hennicke Kamp, Regine Fuchs, Brian N. Chorley, Lize Deferme, Timothy M. D. Ebbels, Jörg Hackermüller, Stefania Perdichizzi, Alan Poole, Ursula G. Sauer, Knut Erik Tollefsen, Tewes Tralau, Carole L. Yauk, B. van Ravenzwaay	25
3	The use of omics-based approaches in regulatory toxicology: an alternative approach to assess the no observed transcriptional effect level 2017 ·Microchemical Journal ·(unknown), Andrea Roli, Elena Morandi, Stefania Perdichizzi, (unknown), Francesca Rotondo, Monica Vaccari, Marco Villani, Roberto Serra, Annamaria Colacci	6
4	A generic Transcriptomics Reporting Framework (TRF) for ‘omics data processing and analysis 2017 ·Regulatory Toxicology and Pharmacology ·Timothy W. Gant, Ursula G. Sauer, Shudong Zhang, Brian N. Chorley, Jörg Hackermüller, Stefania Perdichizzi, Knut Erik Tollefsen, B. van Ravenzwaay, Carole L. Yauk, Weida Tong, Alan Poole	33
5	Identification of pathway-based toxicity in the BALB/c 3T3 cell model 2014 ·Toxicology in Vitro ·Monica Vaccari, Maria Grazia Mascolo, Francesca Rotondo, Elena Morandi, (unknown), Stefania Perdichizzi, (unknown), Stefania Serra, Vanes Poluzzi, Paola Angelini, Sandro Grilli, Annamaria Colacci	16
6	Alternative Testing Methods for Predicting Health Risk from Environmental Exposures 2014 ·Sustainability ·Annamaria Colacci, Monica Vaccari, Maria Grazia Mascolo, Francesca Rotondo, Elena Morandi, (unknown), Stefania Perdichizzi, (unknown), Stefania Serra, Vanes Poluzzi, Paola Angelini, Sandro Grilli, (unknown)	8
7	Cancer-related genes transcriptionally induced by the fungicide penconazole 2013 ·Toxicology in Vitro ·Stefania Perdichizzi, Maria Grazia Mascolo, (unknown), Elena Morandi, Francesca Rotondo, (unknown), (unknown), Monica Vaccari, Annamaria Colacci	31
8	Different sensitivity of BALB/c 3T3 cell clones in the response to carcinogens 2011 ·Toxicology in Vitro ·Annamaria Colacci, Maria Grazia Mascolo, Stefania Perdichizzi, (unknown), (unknown), Francesca Rotondo, Elena Morandi, (unknown), (unknown), Sandro Grilli, Monica Vaccari	14
9	BALB/c 3T3 cell transformation assay for the prediction of carcinogenic potential of chemicals and environmental mixtures 2010 ·Toxicology in Vitro ·Maria Grazia Mascolo, Stefania Perdichizzi, Francesca Rotondo, Elena Morandi, (unknown), (unknown), Monica Vaccari, Sandro Grilli, Annamaria Colacci	33
10	Gene expression time-series analysis of Camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines 2008 ·Molecular Cancer ·Elena Morandi, Cinzia Severini, (unknown), Giovanni D’Ario, Stefania Perdichizzi, Miriam Capri, Giovanna Farruggia, Maria Grazia Mascolo, (unknown), Monica Vaccari, Roberto Serra, Annamaria Colacci, (unknown)	24
11	509 POSTER Evaluation of in vitro toxicity and efficacy of ferutinin, a natural promising chemoprevantive compound 2006 ·European Journal of Cancer Supplements ·Cinzia Severini, Maria Grazia Mascolo, Elena Morandi, (unknown), (unknown), Stefania Perdichizzi, Monica Vaccari, Annamaria Colacci	4
12	Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma 2005 ·European Journal of Cancer ·Katia Scotlandi, Stefania Perdichizzi, Ghislaine Bernard, Giordano Nicoletti, Patrizia Nanni, Pier‐Luigi Lollini, Antonio Curti, Maria Cristina Manara, Stefania Benini, Alain Bernard, Piero Picci	51
13	Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing’s sarcoma 2005 ·European Journal of Cancer ·Katia Scotlandi, Maria Cristina Manara, Claudia Maria Hattinger, Stefania Benini, Stefania Perdichizzi, Michela Pasello, Gaetano Bacci, Licciana Zanella, Franco Bertoni, Piero Picci, Massimo Serra	109
14	Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene 2004 ·Bone ·Cinzia Zucchini, Michele Bianchini, Luisa Valvassori, Stefania Perdichizzi, Stefania Benini, Maria Cristina Manara, Rossella Solmi, Pierluigi Strippoli, Piero Picci, Paolo Carinci, Katia Scotlandi	30
15	Molecular mechanisms of CD99-induced caspase-independent cell death and cell–cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators 2004 ·Oncogene ·Vanessa Cerisano, Yan Aalto, Stefania Perdichizzi, Ghislaine Bernard, Maria Cristina Manara, Stefania Benini, Giovanna Cenacchi, P. Preda, Giovanna Lattanzi, Bálint Nagy, Sakari Knuutila, Mario P. Colombo, Alain Bernard, Piero Picci, Katia Scotlandi	94
16	Contribution of MEK/MAPK and PI3‐K signaling pathway to the malignant behavior of Ewing's sarcoma cells: Therapeutic prospects 2003 ·International Journal of Cancer ·Stefania Benini, Maria Cristina Manara, Vanessa Cerisano, Stefania Perdichizzi, Rosaria Strammiello, Massimo Serra, Piero Picci, Katia Scotlandi	53
17	Impact of IGF-I/IGF-IR Circuit on the Angiogenetic Properties of Ewing’s Sarcoma Cells 2003 ·Hormone and Metabolic Research ·Rosaria Strammiello, Stefania Benini, Maria Cristina Manara, Stefania Perdichizzi, Massimo Serra, Enzo Spisni, Piero Picci, Katia Scotlandi	47
18	The Expression of ccn3(nov) Gene in Musculoskeletal Tumors 2002 ·American Journal Of Pathology ·Maria Cristina Manara, Bernard Perbal, Stefania Benini, Rosaria Strammiello, Vanessa Cerisano, Stefania Perdichizzi, Massimo Serra, Annalisa Astolfi, Franco Bertoni, Jennifer Alami, Herman Yeger, Piero Picci, Katia Scotlandi	94
19	Expression of an IGF‐I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells 2002 ·International Journal of Cancer ·Katia Scotlandi, Sofia Avnet, Stefania Benini, Maria Cristina Manara, Massimo Serra, Vanessa Cerisano, Stefania Perdichizzi, Pier‐Luigi Lollini, Carla De Giovanni, Lorena Landuzzi, Piero Picci	89
20	Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells. 2002 ·PubMed ·Katia Scotlandi, Stefania Perdichizzi, Maria Cristina Manara, Massimo Serra, Stefania Benini, Vanessa Cerisano, Rosaria Strammiello, Mario Mercuri, Gemma Reverter‐Branchat, Glynn Faircloth, Maurizio D’Incalci, Piero Picci	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact